Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Convergence

FDA approves Medtronic’s tablet-controlled pain device

The Intellis system can be programmed via a Samsung's Galaxy S2

- PMLiVE

FDA approves Medtronic’s tablet-controlled pain device

The Intellis system can be programmed via a Samsung's Galaxy S2

Biogen Idec building

Biogen Idec plans phase III Alzheimer’s trial before year-end

And MS drugs drive 2014 sales          

- PMLiVE

Biogen Idec enlists son of NFL star for MS campaign

Tyler Campbell’s own career was cut short by neurological disease

Biogen Idec building

Biogen Idec buys pain specialist Convergence for $675m

Will gain access to lead drug for neuropathic pain

- PMLiVE

FDA adds rare brain infection link to Tecfidera labelling

Biogen Idec’s MS drug gets safety warning

Biogen Idec building

EMA starts review of Biogen Idec’s haemophilia A therapy

Elocta already on the market in the US, Canada and Australia

- PMLiVE

Biogen Idec appoints senior neuroscientists

Christopher Henderson and Richard Ransohoff make the move from academia

- PMLiVE

Biogen Idec names head of gene therapy

Olivier Danos joins from Kadmon Pharmaceuticals

Array appoints Victor Sandor chief medical officer

He joins from Incyte and will replace Michael Needle

- PMLiVE

Adriana Karaboutis joins Biogen Idec from Dell

She is appointed executive vice president, technology and business solutions

- PMLiVE

Pharma takes the ALS Ice Bucket Challenge

GSK, Evotec and Biogen Idec participate in the social media sensation

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links